Developing next generation antibodies into transformative cancer therapies
Compass Therapeutics is a clinical-stage oncology biopharmaceutical company developing proprietary antibody-based therapeutics that target the tumor microenvironment. Their platforms enable rapid identification of therapeutic leads bridging the innate and adaptive immune system, with candidates designed to optimize critical components of anti-tumor immune responses. The company trades on Nasdaq under the ticker CMPX.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2025
Nov 2022
Jul 2018
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
